MADRIGAL PHARMACEUTICALS, INC. (MDGL) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin
Selling, general and administrative [+]	48.1	37.3	21.9	22.6	15.3	7.7	9.3	0.8
General and administrative	48.1	37.3	21.9	22.6	15.3	7.7	9.3	0.8
Research and development	245.4	205.2	184.8	72.3	25.4	24.4	15.9	2.4
EBITDA [+]	-293.1	-242.1	-206.2	-94.9	-40.6	-32.0
EBITDA growth	21.1%	17.4%	117.4%	133.7%	26.9%	26.8%	680.2%	-96.1%
EBITDA margin
Depreciation and amortization	0.5	0.4	0.5	0.1	0.1	0.1
EBIT [+]	-293.6	-242.5	-206.7	-95.0	-40.7	-32.1	-25.2	-3.2
EBIT growth	21.1%	17.3%	117.6%	133.4%	26.9%	27.1%	680.2%	-96.1%
EBIT margin
Interest income, net [+]	-1.8	0.4	4.3	11.0	7.7	0.6	-1.2	-3.6
Interest expense	4.0						1.2	3.6
Interest income	2.2	0.4	4.3	11.0	7.7	0.6	0.0
Other income (expense), net	0.0	0.3	0.1		0.2	0.3
Pre-tax income	-295.4	-241.8	-202.2	-83.9	-32.8	-31.2	-26.4	-6.8
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-295.4	-241.8	-202.2	-83.9	-32.8	-31.2	-26.4	-6.8
Net margin

Basic EPS [+]	($17.24)	($14.63)	($13.09)	($5.45)	($2.22)	($2.54)	($5.07)	($40.03)
Growth	17.9%	11.7%	140.1%	145.9%	-12.8%	-49.8%	-87.3%	4475.3%
Diluted EPS [+]	($17.24)	($14.63)	($13.09)	($5.45)	($2.22)	($2.54)	($5.07)	($40.03)
Growth	17.9%	11.7%	140.1%	145.9%	-12.8%	-49.8%	-87.3%	4475.3%

Shares outstanding (basic) [+]	17.1	16.5	15.4	15.4	14.8	12.2	5.2	0.2
Growth	3.6%	7.0%	0.3%	4.0%	20.8%	135.3%	2943.4%	-99.8%
Shares outstanding (diluted) [+]	17.1	16.5	15.4	15.4	14.8	12.2	5.2	0.2
Growth	3.6%	7.0%	0.3%	4.0%	20.8%	135.3%	2943.4%	-99.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.